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Center for Applied Science and Technology
Bob Carlson, Jacqueline Cofone, Robert Mayo, Scot Remick, Lindsey Gower, Sue LaPierre Anne Breggia

The new MMCRI Center for Applied Science and Technology integrates clinical and research resources for the
advancement of research and development of new technologies that improve patient care and outcomes
Anne Breggia, PhD
Director, MMCRI

Abstract
The journey from basic research to its application in clinical medicine is long and often
fragmented. MaineHealth, as the largest healthcare system in Maine, is uniquely situated to create
synergies between research and clinical medicine. The new MMCRI Center for Applied Science
and Technology is a collaborative effort between the MMC Research Institute (MMCRI) and
NorDx, the MaineHealth Diagnostic Laboratory, that provides the infrastructure needed for
coordinated integration of MMCRI research core facility instrumentation and data resources
with NorDx clinical instrumentation, data resources and support services. The new infrastructure
provided by the Center will facilitate and broaden participation in the vital research needed to
develop new diagnostic tools and therapies that will ultimately improve the health of Maine
people. Approved by MaineHealth and MMCRI leadership in August 2021, the Center is codirected by Anne Breggia, PhD, Director, MMC BioBank and MMCRI Research Laboratory
Services, and by Robert Carlson, MD, NorDx Laboratory Medical Director. Through resource
sharing, Dr. Breggia and Dr. Carlson have facilitated numerous investigator initiated studies,
expanded human sample collection and distribution to support the research of MMC/MMCRI
physicians and scientists, validated a novel SARS-Co-v2 assay based on CRISPR-Cas9 technology
in collaboration with the Broad Institute and successfully executed a variety of Precision
Medicine focused projects that have improved the care of MaineHealth patients. The Center for
Applied Science and Technology moves this successful, collegial collaboration, established in
2019, to a coordinated collaboration enabled by new and existing infrastructure within the clinical
and research domains. By supporting the broad range of research being conducted throughout
the MMCRI research enterprise including the Center for Molecular Medicine, the Center for
Outcomes Research and Evaluation, the Center for Psychiatric Research, the Center for Clinical
and Translational Research, the Clinical Trials Office and the Northern New England Clinical
and Translational Research Network (NNE-CTR), the Center will help move MaineHealth
forward as an academic medical center by creating new opportunities for extramural funding for
research and by facilitating and accelerating scientific discoveries through access to clinical
operations. The Center enables NorDx to develop and validate new testing modalities within a
research regulatory framework that meet evolving Precision Medicine guidelines and allows the
incorporation of emerging technologies into clinical diagnostics for improved patient care and
outcomes. NorDx resources and services available to investigators through the Center include a
research service unit for efficient startup of sponsored and non-sponsored research studies,
phlebotomy services, sample transport services, collection of samples of research value in real
time, biomarker testing on high throughput instrumentation in a CLIA/CAP accredited
laboratory and genomic testing capabilities.

Bob Carlson, MD
Director, NorDx
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Year 1 Goals (August 2021-August 2022)
•
•
•
•
•
•

Budget development
Pursuit of grant funding (PAR-22-088 submitted)
Expansion of the remnant sample program
Phlebotomy and sample transport services for research
MMCRI Website page design
Communication plan for access to services

Long Term Goals
• ISO certification for laboratory testing
• Clinical testing for sponsored clinical trials (NorDx)
• CAP accreditation for research laboratory services
• Digital pathology initiative
• Expansion of ROUX collaborations

Genomic testing (Ion Torrent)

Current investigator initiated research studies supported by the
Center (phlebotomy, sample processing, storage and transport)

•

•
•
•

•

A Period Seroprevalence (SARS-CoV-2) Survey in MHCCN
Cancer Healthcare Workers (HCWs) Providing Patient Care
During the Height of the Outbreak: A Registry Study; Scott
Remick, MD, PI
Cardio-surveillance of MHCCN Cancer Patients Undergoing
Immune Checkpoint Blockade; Sanjeev Francis, MD, PI
NIH RECOVER: A Multi-site Observational Study of PostAcute Sequelae of SARS-CoV-2 Infection in Adults; Cliff Rosen,
MD, PI
NIH national COVID Cohort Collaborative (N3C); Susan
Santangelo, ScD, PI
Non-Invasive Antibody Test for COVID-19 (NIT-COVID);
Doug Sawyer, MD, PhD, PI

